Analyst consensus rating
Belite Bio Analyst Rating: Strong Buy
BLTE is rated Strong Buy by 8 analysts with a $214.00 target. As of 2026-08-18.
Direct answer
Belite Bio's consensus rating is Strong Buy.
8 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $214.00.
Forecast evidence checked August 18, 2026.
Get free Belite Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $162.70
- Average price target
- $214.00
- High price target
- $270.00
- Low price target
- $185.00
- Low target gap
- +13.7%
- Target upside
- +31.5%
- High target gap
- +65.9%
- Target range width
- 52.2%
- Consensus rating
- Strong Buy
- Analysts
- 8
- Evidence date
- August 18, 2026
- Valid through
- August 25, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Belite Bio?
Belite Bio has a verified Strong Buy consensus. The same dataset has an average price target of $214.00.
How far are Belite Bio's low and high targets from the recorded price?
The low target implies +13.7%, while the high target implies +65.9%.
How many analysts are included in Belite Bio's consensus?
The verified consensus includes 8 analysts.
How is Belite Bio's target upside or downside calculated?
The average target of $214.00 is divided by the recorded price of $162.70, then one is subtracted to produce +31.5%. This does not guarantee a future return.
When was Belite Bio's analyst forecast verified?
The data was verified on 2026-08-18. The dataset is valid through 2026-08-25.